Cite

HARVARD Citation

    Pichler, M. et al. (2014). MiR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor. Journal of clinical pathology. 67 (3), pp. 198-203. [Online]. 
  
Back to record